retatrutide trial news New data released on weight loss drug Retatrutide Availability & Timeline |

Molecules 26 (22), 7045

Ensuring equitable access is part of making sure that everyone has the same opportunity to be healthy

Abstract To develop an LCMS/MS method for simultaneous quantification of mildronate and L-carnitine, and to investigate the pharmacokinetic profile of mildronate in rats, its effect on L-carnitine homeostasis, as well as the exposure characteristics, underlying mechanisms, and their associations with therapeutic efficacy and toxicity risks

Gastrointestinal (GI): Nausea is the most common side effect and tends to be dose-dependent

Vitamin B 12 levels can be falsely high or low and data for sensitivity and specificity vary widely

Pairing this IV with glutathione helps to further promote metabolic health and immunity